SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of
1934
[Amendment No. ]
Filed by the Registrant /x/
Filed by a Party other than the Registrant / /
Check the appropriate box:
/ /Preliminary Proxy Statement
/x/Definitive Proxy Statement
/ /Definitive Additional Materials
/ /Soliciting Material Pursuant to Section 240.14a-11(c) or Section 240.14a-
12
THE PROCTER & GAMBLE COMPANY
(Name of Registrant as Specified in Its Charter)
TERRY L. OVERBEY
(Name of Person(s) Filing Proxy Statement
Payment of Filing Fee (Check the appropriate box):
/x/$125 per Exchange Act Rules 0-11)(c)(1)(ii), 14a-6(j)(2).
/ /$500 per each party to the controversy pursuant to Exchange Act
Rule 14a-6(i)(3).
/ /Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
1) Title of each class of securities to which transaction applies:
..........................................................
2) Aggregate number of securities to which transaction applies:
..........................................................
3) Per unit price or other underlying value of transaction
computed pursuant to Exchange Act Rule 0-11:*
..........................................................
4) Proposed maximum aggregate value of transaction:
..........................................................
*Set forth the amount on which the filing fee is calculated and state how
it was determined.
/ /Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
1) Amount Previously Paid: ________________________________
2) Form Schedule or Registration Statement No.: ___________
3) Filing Party: __________________________________________
4) Date Filed: ____________________________________________
<PAGE>
P&G
T H E P R O C T E R & G A M B L E C O M P A N Y
NOTICE OF ANNUAL MEETING
AND
PROXY STATEMENT
ANNUAL MEETING OF
SHAREHOLDERS
OCTOBER 11, 1994
<PAGE>
P&G
THE PROCTER & GAMBLE COMPANY
PO BOX 599
CINCINNATI, OHIO 45201-0599
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
September 2, 1994
The annual meeting of shareholders of The Procter & Gamble Company will
be held at the General Offices of the Company, Two Procter & Gamble Plaza,
Cincinnati, Ohio 45202-3314 on Tuesday, October 11, 1994 at 12 o'clock
noon, Eastern Daylight Time. Attendance at the annual meeting will be
limited to shareholders, those holding proxies from shareholders and
representatives of the press and financial community. If you wish to
attend the meeting but your shares are held in the name of a broker, trust,
bank or other nominee, you should bring with you a proxy or letter from the
broker, trustee, bank or nominee confirming your beneficial ownership of
the shares.
The purposes of this meeting are:
A. To hear the reading of the minutes of the annual meeting of
shareholders held October 12, 1993 and to act thereon if they are
incorrectly recorded;
B. To receive reports of officers;
C. To elect six members of the Board of Directors with terms expiring
at the annual meeting in 1997, as described at pages 3-4 in the
accompanying proxy statement;
D. To consider and act upon a proposal described at page 18 in the
proxy statement to ratify the appointment of independent auditors;
E. To consider and act upon a proposal described at page 19 in the
proxy statement to ratify the adoption of The Procter & Gamble 1993
Non-Employee Directors' Stock Plan;
F. To consider and act upon, if presented at the meeting, proposals
submitted by certain shareholders as described at pages 19-24 in
the proxy statement; and
G. To consider such other matters as may properly come before the
meeting.
Shareholders of record at the close of business on Friday,
August 12, 1994 will receive notice of and be entitled to vote at the
meeting.
Shareholder attendees who are hearing-impaired should identify
themselves on registration at the meeting so they can be directed to a
special section where an interpreter will be available.
A copy of the annual report of the Company for the fiscal year ended
June 30, 1994 has been mailed to each shareholder of record as of
August 12, 1994.
SHAREHOLDERS ARE URGED TO EXECUTE THE ENCLOSED PROXY AND RETURN IT
PROMPTLY, WHETHER OR NOT THEY EXPECT TO ATTEND THE MEETING. ANY PROXY NOT
DELIVERED AT THE MEETING SHOULD BE MAILED TO REACH THE COMPANY'S PROXY
TABULATOR, CHEMICAL BANK, CHURCH STREET STATION, PO BOX 24966, NEW YORK, NY
10242-4966 BY 9:00 A.M. ON TUESDAY, OCTOBER 11, 1994 (OR USE THE ENCLOSED
SPECIAL POSTAGE-PAID ENVELOPE FOR MAILING IN THE UNITED STATES).
By order of the Board of Directors,
TERRY L. OVERBEY
Secretary
<PAGE>
PROXY STATEMENT
THE PROCTER & GAMBLE COMPANY
ANNUAL MEETING OF SHAREHOLDERS TO BE HELD OCTOBER 11, 1994
SOLICITATION AND REVOCATION OF PROXIES
The enclosed proxy is being solicited by the Board of Directors of the
Company. In addition to the solicitation by mail, proxies may be solicited
in person or by telephone or telegraph; such solicitation on behalf of the
Proxy Committee of the Board may be made by Directors, officers and regular
employees of the Company and by representatives of Georgeson & Company
Inc., a proxy solicitation firm. The Company has agreed to pay Georgeson &
Company Inc. a fee of $16,000, plus reasonable expenses, for its services
in this regard. Any proxy given pursuant to this solicitation may be
revoked by notice from the person giving the proxy at any time before it is
exercised. Any such notice of revocation should be provided in writing
signed by the shareholder in the same manner as the proxy being revoked and
delivered to the Company's proxy tabulator, Chemical Bank, Church Street
Station, PO Box 24966, New York, NY 10242-4966.
The expense of making the solicitation will consist of preparing and
mailing the proxies and proxy statements; any expenses incurred by Company
representatives in making the contacts referred to above; charges of
brokerage houses and other custodians, nominees or fiduciaries for
forwarding documents to security owners; costs of returning the proxies;
and fees of Chemical Bank for tabulating the responses. These are the only
contemplated expenses of solicitation, and they will be paid by the
Company.
VOTING RIGHTS
The holders of record of the Company's Common Stock and Series A and B
ESOP Convertible Class A Preferred Stock at the close of business on
Friday, August 12, 1994 are entitled to vote on matters to come before the
meeting. On that date, 684,700,179 shares of Common Stock, 34,108,617
shares of Series A ESOP Convertible Class A Preferred Stock and 19,142,418
shares of Series B ESOP Convertible Class A Preferred Stock were issued and
outstanding. As provided in the Amended Articles of Incorporation, each
share of Common and Series A and B ESOP Convertible Class A Preferred Stock
is entitled to one vote.
Participants in The Procter & Gamble Dividend Reinvestment Plan (for
public shareholders) and The Procter & Gamble Stock Investment Program (for
employees and retirees) are entitled to vote shares of the Company's Common
Stock held for their account under these programs pursuant to omnibus
proxies executed in their favor by the Trustee of such programs, Morgan
Guaranty Trust Company of New York.
Participants in The Procter & Gamble Profit Sharing Trust and Employee
Stock Ownership Plan and The Procter & Gamble/Noxell Transitional Plan have
the right to instruct the Trustees of any Trust under such Plans in which
they are participating as to how to vote shares of stock allocated to their
accounts. The Plans also provide that the Trustees of each Trust shall
vote any shares allocated to accounts of participants as to which such
instructions have not been received, in direct proportion to the voting of
allocated shares as to which voting instructions have been received. In
addition, the Plans provide that the Trustees shall vote unallocated shares
of stock held in such a Trust in direct proportion to the voting of
allocated shares in such Trust as to which voting instructions have been
received.
The vote required for the election of Directors and approval of the
other proposals is set forth in the discussion of each item to be voted
upon.
<PAGE>
ELECTION OF DIRECTORS
The Regulations of the Company provide that the Board of Directors shall
consist of three classes of Directors with overlapping three-year terms.
One class of Directors is to be elected each year with terms extending to
the third succeeding annual meeting after such election. The Regulations
provide that the Board shall maintain the three classes so as to be as
nearly equal in number as the then total number of Directors permits.
Pursuant to the provisions of the Regulations described above, there are
six Directors of the Company whose terms expire at the annual meeting in
1994. The six Directors whose terms are expiring in 1994 are described in
the section immediately below. It is the Board's intention that these six
persons will be nominated for new terms extending to the annual meeting in
1997 and until their successors are duly elected. Proxies received in
response to this solicitation will be voted, unless such authority is
withheld, in favor of the election of the six nominees named in that
section. In the election of members of the Board of Directors the six
candidates receiving the most votes will be elected. While there is no
reason to believe that any of the nominees will, prior to the date of the
meeting, refuse or be unable to accept the nomination, should any nominee
or nominees so refuse or become unable to accept, it is the intention of
the persons named in the proxy to vote for such other person or persons as
the Directors may recommend.
Directors whose terms expire at the annual meetings in 1995 and 1996 are
described in separate sections below.
NOMINEES FOR ELECTION AS DIRECTORS WITH TERMS EXPIRING IN 1997
David M. Abshire, Ph.D. - President, Center for Strategic and International
Studies, Washington, DC. Director of Ogden Corporation; Director of
the Company since 1987; member of the Audit and Nominating Committees;
age 68.
Edwin L. Artzt - Chairman of the Board and Chief Executive. Director of
American Express Company, Delta Air Lines, Inc., GTE Corporation and
Teradyne, Inc.; Director of the Company from 1972 to 1975 and since
1980; member of the Executive Committee; age 64.
Norman R. Augustine - Chairman and Chief Executive Officer, Martin Marietta
Corporation (aerospace, electronics, information management, materials
and energy systems and products). Director of Martin Marietta
Corporation and Phillips Petroleum Company; Director of the Company
since 1989; Chairman of the Compensation Committee and member of the
Executive Committee; age 59.
Richard J. Ferris - Co-Chairman, Doubletree Corporation. Director of
Doubletree Corporation and Amoco Corporation; Director of the Company
since 1979; member of the Audit, Executive and Nominating Committees;
age 58.
John G. Smale - Retired Chairman of the Board and Chief Executive.
Chairman of the Board of Directors of General Motors Corporation;
Director of J. P. Morgan & Co. Incorporated and its subsidiary Morgan
Guaranty Trust Company of New York; Director of the Company since 1972;
Chairman of the Executive Committee; age 67.
Marina v.N. Whitman, Ph.D. - Professor of Business Administration and
Public Policy, University of Michigan. Director of Aluminum Company of
America, Browning-Ferris Industries, Inc., Chemical Banking Corporation
and its subsidiary Chemical Bank, and Unocal Corporation; Director of
the Company since 1976; Chairman of the Nominating Committee and member
of the Audit and Compensation Committees; age 59.
All of the nominees for election as Directors with terms expiring in
1997, except Mr. Ferris and Dr. Whitman, have been, or were prior to
retirement, executive officers of their respective employers for more than
the past five years. Prior to his association with Doubletree Corporation
(formerly Guest Quarters Hotels LP) in October, 1992, Mr. Ferris was a
private investor for more than five years following his resignation as
Chairman and Chief Executive Officer of UAL Corporation (formerly Allegis
Corporation -
<PAGE>
travel related services) in June, 1987. Prior to her appointment at the
University of Michigan effective September 1, 1992, Dr. Whitman was Vice
President and Group Executive, General Motors Corporation, for more than
five years.
DIRECTORS WITH TERMS EXPIRING IN 1995
Joseph T. Gorman - Chairman and Chief Executive Officer, TRW Inc.
(electronic, automotive, industrial and aerospace equipment). Director
of TRW Inc. and Aluminum Company of America; Director of the Company
since 1993; member of the Compensation and Nominating Committees; age
56.
Robert A. Hanson - Retired Chairman and Chief Executive Officer, Deere &
Company (agricultural and industrial equipment). Director of Dun &
Bradstreet, R. R. Donnelly & Sons Company and Merrill Lynch & Co.,
Inc.; Director of the Company since 1983; member of the Compensation
and Executive Committees; age 69.
Jerry R. Junkins - Chairman, President and Chief Executive Officer, Texas
Instruments Incorporated (semiconductors, defense electronic systems
and other electronic products). Director of Texas Instruments
Incorporated, Caterpillar, Inc. and 3M; Director of the Company since
1988; Chairman of the Audit Committee and member of the Compensation
and Executive Committees; age 56.
Joshua Lederberg, Ph.D. - Professor and President Emeritus, The Rockefeller
University. Director of the Company since 1984; member of the Audit
and Nominating Committees; age 69.
John E. Pepper - President. Director of Xerox Corporation; Director of the
Company since 1984; age 56.
Robert D. Storey - Partner in the law firm of Thompson, Hine and Flory,
Cleveland, Ohio. Director of Bank One, Cleveland, GTE Corporation and
The May Department Stores Company; Director of the Company since 1988;
member of the Audit and Nominating Committees; age 58.
All of the Directors with terms expiring in 1995, except Mr. Storey,
have been, or were prior to retirement, executive officers of their
respective employers for more than the past five years. Mr. Storey was a
partner in the law firm of Burke, Haber & Berick Co., L.P.A. and its
successor firm, McDonald, Hopkins, Burke & Haber Co., L.P.A., Cleveland,
Ohio, for more than five years prior to joining Thompson, Hine and Flory on
January 1, 1993.
Each of the Directors with terms expiring in 1995 was elected a Director
by the shareholders at the annual meeting in 1992 except Mr. Gorman, who
was elected a Director on December 8, 1992 to fill a vacancy resulting from
a retirement from the Board.
DIRECTORS WITH TERMS EXPIRING IN 1996
Donald R. Beall - Chairman and Chief Executive Officer, Rockwell
International Corporation (electronics, aerospace, automotive
components, industrial automation and graphics systems). Director of
Rockwell International Corporation, Amoco Corporation and Times-Mirror
Company; Director of the Company since 1992; member of the Compensation
and Nominating Committees; age 55.
Gordon F. Brunner - Senior Vice President. Director of the Company since
1991; age 55.
Richard B. Cheney - Senior Fellow, American Enterprise Institute for Public
Policy Research, Washington, DC. Director of IGI Inc., Morgan Stanley
& Co., Incorporated, Union Pacific Corporation and U S WEST, Inc.;
Director of the Company since 1993; member of the Audit and Nominating
Committees; age 53.
Harald Einsmann - Group Vice President. Director of Thorn EMI plc;
Director of the Company since 1991; age 60.
Durk I. Jager - Executive Vice President. Director of the Company since
1989; age 51.
<PAGE>
Charles R. Lee - Chairman and Chief Executive Officer, GTE Corporation
(telecommunication services). Director of GTE Corporation, Contel
Cellular Inc., United Technologies Corporation and USX Corporation.
Director of the Company since March 8, 1994; member of the Audit and
Nominating Committees; age 54.
All of the Directors with terms expiring in 1996 have been executive
officers of their respective employers for more than the past five years
except Mr. Cheney. Mr. Cheney has been a Senior Fellow at the American
Enterprise Institute for Public Policy Research, Washington, DC, since
January, 1993. Prior to that, Mr. Cheney was Secretary of Defense of the
United States from March 17, 1989 to January 20, 1993, following service as
a member of the U.S. House of Representatives since 1978.
Each of the Directors with terms expiring in 1996 was elected a Director
by the shareholders at the annual meeting in 1993 except Mr. Lee . Mr. Lee
was elected a Director on March 8, 1994 to succeed Gerald V. Dirvin
effective upon his retirement.
COMMITTEES OF THE BOARD
The EXECUTIVE COMMITTEE (established in 1905). As prescribed by the
Regulations of the Company, the Committee has the authority of the Board of
Directors for the management of the business and affairs of the Company
between meetings of the Board.
The AUDIT COMMITTEE (established in 1940) met five times during the
fiscal year ended June 30, 1994 with representatives of Deloitte & Touche
and financial management to review accounting, control, auditing and
financial reporting matters. The Committee is responsible, among other
things, for recommending to the Board the firm of independent auditors to
be retained, approving professional services rendered and reviewing the
scope of the annual audit and reports and recommendations submitted by the
independent audit firm, which regularly meets privately with the Committee.
The NOMINATING COMMITTEE (established in 1972) met seven times during
the fiscal year ended June 30, 1994. The Nominating Committee is
responsible for establishing the criteria for and reviewing the
qualifications of individuals for election as members of the Board. When a
vacancy on the Board occurs or is anticipated the Committee presents its
recommendation of a replacement Director to the Board. The Committee also
makes recommendations as to exercise of the Board's authority to determine
the number of its members, within the limits provided by the Regulations of
the Company. Shareholders wishing to communicate with the Nominating
Committee concerning potential Director candidates may do so by
corresponding with the Secretary of the Company and including the name and
biographical data of the individual being suggested.
The COMPENSATION COMMITTEE met five times during the fiscal year ended
June 30, 1994. The Compensation Committee (or its predecessor Committees,
which served the same function under different names and which were
established commencing in 1960) is responsible for fixing or agreeing to
the salary and other compensation of all principal officers of the Company
elected by the Board, and advising the Chief Executive on policy matters
concerning officers' compensation. The Compensation Committee is also
responsible for administration of The Procter & Gamble 1992 Stock Plan as
approved at the annual meeting of shareholders on October 13, 1992. The
authority of the Committee under the Plan includes selection of key
employees for participation in the Plan and determination of numbers of
stock options and stock appreciation rights and amounts of restricted and
unrestricted stock to be awarded to such employees pursuant to the Plan.
The Committee is also charged with on-going administration and
interpretation of the Plan and of its predecessor plans, The Procter &
Gamble 1983 Stock Plan and the Plan for Use of Shares in Payment of
Remuneration, both of which have been superseded as to new grants by The
Procter & Gamble 1992 Stock Plan.
<PAGE>
CERTAIN ADDITIONAL INFORMATION CONCERNING THE BOARD OF DIRECTORS
During the fiscal year ended June 30, 1994 a total of 11 meetings of the
Board and 18 meetings of Committees of the Board were held. Average
attendance at these meetings by nominees and incumbents serving as
Directors during the past year was in excess of 94%.
During the fiscal year ended June 30, 1994 Directors who were not
employees of the Company were paid retainers at the rate of $30,000 per
year, plus a fee of $1,000 for each Board or Board Committee meeting
attended. In addition, non-employee Directors who served on Board
Committees were paid retainers at the rate of $5,000 (for Committee
Chairmen) or $3,000 (for Committee members) per year. The Company does not
pay directors' fees to Directors who are employees of the Company.
Directors who are not employees of the Company are also provided insurance
coverage in the amount of $750,000 payable in the event of accidental death
or disability occurring while traveling on Company business. Such
Directors also receive reimbursement for expenses of such travel.
Fees otherwise payable to a Director who has elected to come under The
Procter & Gamble Deferred Compensation Plan for Directors are credited to
such Director's account but not funded. Interest is credited to such an
account at the end of each month at the prime rate then in effect at Morgan
Guaranty Trust Company of New York. Such a deferred compensation account
is payable either upon the retirement of the Director or after a term of
years specified by the electing Director, at the Director's option, elected
in advance of being earned. Directors may also elect to convert a portion
or all of their fees for services as a Director into Common Stock of the
Company pursuant to The Procter & Gamble 1993 Non-Employee Directors' Stock
Plan.
Directors who are not employees of the Company are covered by a
retirement plan pursuant to which retirement benefits are payable to any
such Director who has served at least five years since original election to
the Board. The annual retirement benefit under this plan is specified as
the amount of the annual retainer for Board service in effect at the time
of retirement, payable quarterly for as many calendar quarters following
retirement as the retired Director served prior to retirement, or until
death, whichever occurs first. This retirement benefit is partly in
recognition of the availability of retired Directors as a continuing
resource for consultation by the Chief Executive as appropriate. There are
no survivor benefits payable under this plan.
Effective January 1, 1992, as part of its overall program of support for
charitable institutions and as an aid in attracting and retaining qualified
Directors, the Board of Directors established a Charitable Gifts Program
funded by life insurance on the lives of the non-employee members of the
Board of Directors and the Chairman of the Board and Chief Executive.
Directors derive no financial benefit from the Program since all insurance
proceeds and charitable deductions accrue solely to the Company. Under
this Program the Company intends to make charitable contributions of up to
a total of $1 million following the death of any such participant with such
contribution to be allocated in accordance with each participant's
recommendations among up to five charitable organizations. The following
current and retired Directors of the Company are participants in this
Program: David M. Abshire, Edwin L. Artzt, Norman R. Augustine, Donald R.
Beall, Theodore F. Brophy, Richard B. Cheney, Richard J. Ferris, Joseph T.
Gorman, Robert A. Hanson, Jerry R. Junkins, Joshua Lederberg, Charles R.
Lee, Walter F. Light, David M. Roderick, John G. Smale, Robert D. Storey
and Marina v.N. Whitman. Beneficiary organizations designated under this
Program must be tax-exempt under Section 501(c)(3) of the Internal Revenue
Code, and donations ultimately paid by the Company will be deductible
against federal and other income taxes payable by the corporation in
accordance with the tax laws applicable at the time. Because of such
deductions and use of insurance, the Program should result in little or no
long-term cost to the Company under present law.
<PAGE>
REPORT OF THE COMPENSATION COMMITTEE OF THE
BOARD OF DIRECTORS ON EXECUTIVE COMPENSATION
OVERVIEW
The Compensation Committee of the Board of Directors (the "Committee")
consists entirely of outside, non-employee Directors. The Committee
establishes and regularly reviews executive compensation levels and
policies, and authorizes short- and long-term awards in the form of cash or
stock. All awards are made within the authority of the Additional
Remuneration Plan, which dates back to 1949, and The Procter & Gamble 1992
Stock Plan.
Compensation for executives is based on the principles that compensation
must (a) be competitive with other quality companies in order to help
acquire, motivate and retain the talent needed to lead and grow Procter &
Gamble's business; and (b) provide a strong incentive for key managers to
achieve the Company's goals.
Procter & Gamble has an enviable record of recruiting, training and
developing all of its executive talent from within -- an achievement few
other corporations have matched. In addition, the Company's long-term
performance, as measured by sales and earnings growth and other relevant
measures, has been very positive. This record suggests the principles that
drive our compensation program have, over time, delivered the desired
results.
Executive compensation is based on performance against a combination of
financial and non-financial measures including business results and
developing organization capacity. In addition, employees are expected to
uphold the fundamental principles embodied in the Company's Statement of
Purpose and Environmental Quality Policy. These include a commitment to
integrity, doing the right thing, maximizing the development of each
individual, developing a diverse organization, and continually improving
the environmental quality of our products and operations. In upholding
these financial and non-financial objectives, executives not only
contribute to their own success, but also help ensure our business,
employees, shareholders and the communities in which we live and work will
prosper.
ELEMENTS OF EXECUTIVE COMPENSATION
It is the Company's long-standing policy that variable, at-risk
compensation, both annual and long-term, should make up a significant
portion of executive compensation. Depending upon the level of the
executive, the Company targets between 40% and 60% of executive
compensation (other than retirement credits) to be variable, at-risk
elements. When the Company achieves solid earnings growth and stock price
appreciation, executive compensation levels will equal or exceed the middle
compensation range for a comparative group of companies. This group
includes a combination of leading consumer products companies and other
corporations of size and reputation comparable to Procter & Gamble (and
with which Procter & Gamble must compete in hiring and retaining the
employees it needs). The composition of this group is updated
periodically.
The Committee believes the compensation levels of the Company's
executive officers are competitive and in line with those of comparable
companies.
Annual compensation elements include base salary and two forms of
incentives, the Performance Bonus Award and the Profit Incentive Award.
Long-term incentive compensation includes stock options and an Earnings
Progress Award (cash or stock) related to real (greater than average growth
of the economy) earnings per share growth.
In addition, executives participating in The Procter & Gamble Profit
Sharing Trust and Employee Stock Ownership Plan receive retirement awards
in the form of stock restricted (non-transferable and subject to
forfeiture) until retirement, or in some cases, cash deferred until
retirement. These awards make up the difference between the Internal
Revenue Code limit on contributions that can be made to that Plan and what
<PAGE>
would normally be contributed by the Company to the executive's account.
The Procter & Gamble Profit Sharing Trust and Employee Stock Ownership Plan
is a qualified plan providing retirement benefits for U.S.-based employees.
ANNUAL COMPENSATION
Annual compensation consists of base salary and two forms of annual
incentives.
Executive pay ranges are established based on a careful examination of
survey data from a comparative group of companies gathered by a leading
consulting firm specializing in executive compensation. A number, but not
all, of these companies are included in the line of business index shown on
the performance graph. Executive compensation ranges are targeted to be in
the middle of this group of companies. Within the established range
structure, the Committee approves changes in amounts of executive
compensation based on individual performance evaluations and time in
position.
One annual incentive award, the Performance Bonus Award, is based on an
evaluation of each executive's individual performance. A separate annual
award, the Profit Incentive Award, is tied to the net profit achievement of
the Company and/or certain business units as compared to preset goals. If
these profits, after any adjustments for unusual items, are not delivered,
no awards are made.
Senior management and the Committee believe that differences in
performance should result in significantly different levels of annual cash
compensation.
LONG-TERM INCENTIVES
Long-term incentives consist of stock options and Earnings Progress
Awards, with the latter consisting of cash or stock awards related to
earnings per share growth. Both types of awards serve to focus executive
attention on the long-term performance of the business.
The Company makes stock option grants annually at no less than 100% of
the market price on the date of grant. Stock appreciation rights (SARs)
are granted instead of options in a few countries where the holding of
foreign stock is restricted. These grants and rights are fully exercisable
after one year and have a ten year life. The number of shares normally
awarded is based on a formula that uses a multiple of annual compensation
divided by the average stock price over the past five years. Option awards
will vary in size based on position level (more senior managers receive a
higher multiple) and performance evaluation ratings. These awards are
designed to be competitive with awards made by companies in the survey
group. The number of option shares currently held by each executive is not
considered in determining awards. Grants are only made to employees who
have demonstrated a capacity for contributing in a substantial way to the
success of the Company. Stock options encourage these managers to become
owners of the business, which helps to further align their interests with
the shareholders. Options have no value unless the price of the Company's
stock increases, since they are exercisable only by the employee and cannot
be transferred except in case of death.
To support the Company's desire to increase management's stock
ownership, the Committee approved a share retention program for managers
participating in the stock option program. Specific guidelines require
optionees to achieve and then retain a multiple of their base salary in
shares of Procter & Gamble stock. Higher level managers are required to
retain a larger multiple. The Chief Executive's multiple is three times
base salary. Stock options which lead to equity ownership in the Company
provide a direct link between executive compensation and shareholder value
creation.
Earnings Progress Awards in the form of restricted stock or deferred cash
related to real growth in earnings per share are made to only our highest
level managers. These awards are made only when earnings per share, after
any adjustments for unusual items, increase over the most recent three-year
period at a rate in excess of the Gross Domestic Product Implicit Price
Deflator ("GDP deflator") which measures the overall growth in the economy.
For the purpose of calculating awards under this program, 1993-94 earnings
per share was lowered for all participants to remove the positive earnings
impact arising from the strategic restructuring and other related business
actions taken last year as committed to by the Committee.
<PAGE>
Awards can range from 0% to 100% of the Performance Bonus Award. No
awards are paid if the Company's three-year average earnings per share
growth does not exceed the three-year average GDP deflator movement by at
least one percent. Also, the Company's latest fiscal year's earnings per
share, adjusted for unusual items, must exceed that of the prior year.
These awards are generally made in the form of stock, restricted for a term
of years or until retirement.
Except for certain executives who were directly involved in the
derivatives transactions that resulted in the $102MM after-tax charge to
earnings, the Committee felt the Company's incentive plan participants
should not have their compensation negatively affected in a year where their
efforts resulted in record profits and unit volume, increased market share
and improved profit margins.
The Committee has reviewed the new federal tax legislation limiting the
deduction available for compensation paid to the Company's named executives
under Internal Revenue Code Section 162(m). Although the Internal Revenue
Service has not yet issued final regulations interpreting Section 162(m),
the Committee believes that option and SAR grants under the 1992 Stock Plan
meet the requirements for deductible compensation. The Committee will
review the Company's executive compensation plans over the next year to
determine what changes, if any, should be made as a result of the Section
162(m) limitation on deductibility. The potential tax liability from the
loss of deductibility over the next year is nominal.
COMPENSATION OF THE CHIEF EXECUTIVE
The compensation of Edwin L. Artzt, Chairman of the Board and Chief
Executive, consists of the same elements as for other senior executives,
namely base salary, annual incentives, stock options, and awards for real
growth in earnings per share.
In determining Mr. Artzt's compensation package, the Committee reviewed
the Company's financial and business performance for 1993-94. This review
was based on a number of factors including sales, earnings, unit volume,
market share, profit margins, return on equity, growth in earnings, and
total shareholder return. The Committee does not assign relative weights or
rankings to each of these factors, but instead makes a subjective
determination based on consideration of all such factors. In addition, the
Committee also noted significant progress in the Company's long-term
initiatives. Profit centers in all parts of the business are successfully
bringing savings to the bottom line as a result of restructuring efforts.
The Company's strategy of offering consumers products providing better value
continues to move ahead worldwide. The Company has made strategic
investments in International acquisitions and joint ventures as well as a
number of brand expansions and new brands that will support the Company's
long-term growth expectations.
Mr. Artzt's base salary was established based on the Committee's
evaluation of his performance toward the achievement of the Company's
financial, strategic and other goals, his length of service as Chief
Executive, and competitive chief executive officer pay information. His
Performance Bonus Award was based on the Committee's overall evaluation of
his individual performance.
Although the final amount has not yet been determined, it is expected
that Mr. Artzt will qualify for a Profit Incentive Award for 1993-94 in the
amount of approximately $420,000. Mr. Artzt requested the Committee to
reduce his expected award by $100,000, as he did not feel he should receive
his full award in a year in which earnings were affected by the derivatives
charge. The Committee accepted Mr. Artzt's compensation reduction request
even though he was not involved in the transactions and was not aware of
the problem until shortly before the public disclosure on April 12, 1994.
The Committee noted that Mr. Artzt's compensation would be viewed as
conservative versus competitive levels even before the voluntary reduction.
The Chief Executive's Earnings Progress Award reflecting real growth in
earnings per share, after adjustments for unusual items, over the most
recent three fiscal years was calculated on the same basis as for all other
covered executives. It was equal to 36.5% of his Performance Bonus Award.
<PAGE>
Mr. Artzt's 1994 stock option grant, as with other optionees, was based
on competitive survey data and the Committee's judgment of Mr. Artzt's
strategic contributions to the long-term success of the Company.
Norman R. Augustine, Chairman Joseph T. Gorman
Donald R. Beall Jerry R. Junkins
Robert A. Hanson Marina v.N. Whitman
EXECUTIVE COMPENSATION TABLES
The following tables and notes present the compensation provided by the
Company to its Chief Executive officer, and to each of the Company's four
most highly compensated executive officers, other than the Chief Executive,
for services rendered in all capacities to the Company for the fiscal years
ended June 30, 1994, 1993, and 1992.
<TABLE>
SUMMARY COMPENSATION TABLE
(DOLLAR FIGURES SHOWN IN THOUSANDS)
<CAPTION>
Name and Annual Compensation
______________________________________________
Principal Other Annual
Position Year Salary Bonus(1) Compensation(2)
_______________ _______ ________ ________ _______________
<S> <C> <C> <C> <C>
Edwin L. Artzt 1993-94 $1,270.0 $1,020.0 $0
Chairman of the 1992-93 1,137.5 981.3 0
Board and Chief 1991-92 1,012.5 575.0 0
Executive
John E. Pepper 1993-94 $910.0 $704.0 $0
President 1992-93 835.0 645.3 0
1991-92 835.0 756.6 0
Durk I. Jager 1993-94 $672.5 $574.6 $(28.6)(6)
Executive Vice 1992-93 576.7 444.4 (32.7)(6)
President 1991-92 485.0 250.0 (11.5)(6)
Harald Einsmann 1993-94 $565.0 $463.8(7) $249.9(8)
Group Vice 1992-93 512.5 465.2(7) 440.5(8)
President 1991-92 495.0 454.6(7) 467.0(8)
Gordon F. Brunner 1993-94 $475.0 $372.4 $0
Senior Vice 1992-93 450.0 290.9 0
President 1991-92 408.3 221.1 0
<CAPTION>
Long-Term Compensation
Awards
_______________________
Securities
Name and Restricted Underlying
Principal Stock Options/ All Other
Position Awards(3)(4) SARs Compensation(5)
________________ ____________ __________ _______________
<S> <C> <C> <C>
Edwin L. Artzt $255.8 64,000 $334.9
Chairman of the 262.8 61,000 301.2
Board and Chief 575.0 66,000 269.9
Executive
John E. Pepper $160.7 45,000 $239.1
President 174.5 48,000 223.5
390.0 54,000 222.0
Durk I. Jager $124.2 35,000 $168.8
Executive Vice 122.0 29,000 145.4
President 250.0 32,000 126.9
Harald Einsmann $55.8 24,000 $256.5
Group Vice 67.3 22,000 237.1
President 145.4 27,000 243.8
Gordon F. Brunner $82.2 18,000 $125.4
Senior Vice 79.9 20,000 118.7
President 175.0 11,000 108.6
<FN>
(1) Although the final amount
of the Profit Incentive Award for fiscal 1993-94 has not yet been
determined, the amount of the expected award has been included.
(2) Any perquisites or other
personal benefits received from the Company by any of the named
executives were substantially less than the reporting thresholds
established by the Securities and Exchange Commission (the lesser of
$50,000 or 10% of the individual's cash compensation).
(3) Restricted stock is
awarded for growth in earnings per share in excess of the GDP deflator
over the most recent three-year period as discussed in the Compensation
Committee Report. Restricted stock awarded to the named executives for
fiscal year 1993-94 will vest on June 20, 1999 or on retirement, except
for Mr. Einsmann whose award of 1,010 shares will vest on June 20,
1995.
(4) The number and value (in
thousands of dollars) of aggregate restricted stock holdings of each of
the named executives on June 30, 1994 was: Mr. Artzt, 72,821 shares
($3,936.9); Mr. Pepper, 79,787 shares ($4,313.5); Mr. Jager, 22,129
shares ($1,196.3); Mr. Einsmann, 0 shares ($0); Mr. Brunner, 19,463
shares ($1,052.2). The value of the restricted stock is determined by
multiplying the total shares held by
<PAGE>
each named executive by the average high and low price on the New York
Stock Exchange on June 30, 1994 ($54.0625). Dividends are paid on all
restricted Common Stock at the same rate as paid on the Company's
Common Stock.
(5) All Other Compensation (in
thousands of dollars) -- details for 1993-94:
<CAPTION>
Total
Flexible Imputed International All
Profit Sharing Compensation Income Assignment Other
and Related Program Life Equalization Compen-
Name Contributions Contributions Insurance Payments sation
_________ _____________ ____________ ________ ____________ _______
<S> <C> <C> <C> <C> <C>
Edwin L. Artzt $283.6 $45.5 $5.8$ 0 $334.9
John E. Pepper 203.2 33.4 2.5 0 239.1
Durk I. Jager 150.2 17.3 1.3 0 168.8
Harald Einsmann 0 0 1.8 254.7 256.5
Gordon F. Brunner 106.1 18.0 1.3 0 125.4
(6) Reimbursement to the Company of foreign tax credits
attributable to previous tax equalization payments pertaining to Mr.
Jager's earlier service in Japan, as paid in accordance with Company
policies applicable generally to managers assigned outside their home
countries.
(7) Includes certain amounts of income taxes payable to
Belgium on awards of restricted stock, as follows (in thousands of
dollars): 1991-92, $54.6; 1992-93, $25.2; and 1993-94, $31.8.
(8) Tax equalization payments to cover incremental taxes
required to be paid to Belgium (Mr. Einsmann), as paid in accordance
with Company policies applicable generally to managers assigned outside
their home countries.
</TABLE>
<PAGE>
<TABLE>
OPTION GRANTS IN LAST FISCAL YEAR
(DOLLAR FIGURES SHOWN IN THOUSANDS)
<CAPTION>
% of
Total
Number of Options
Securities Granted to
Underlying Employees
Options in Exercise or Expiration
Name Granted(1) Fiscal Year Base Price Date
_____________ __________ ___________ ___________ __________
<S> <C> <C> <C> <C>
Edwin L. Artzt 64,000 1.6% $56.8125 2/25/04
John E. Pepper 45,000 1.2% 56.812 2/25/04
Durk I. Jager 35,000 0.9% 56.8125 2/25/04
Harald Einsmann 24,000 0.6% 56.8125 2/25/04
Gordon F. Brunner 18,000 0.5% 56.8125 2/25/04
<CAPTION>
Potential
Realizable Value
at Assumed Annual
Rates of Stock
Price Appreciation
for Option Term (2)
___________________
(a) (b)
Name 5% 10%
_______________ ________ ________
<S> <C> <C>
Edwin L. Artzt $2,286.7 $5,794.8
John E. Pepper 1,607.8 4,074.5
Durk I. Jager 1,250.5 3,169.1
Harald Einsmann 857.5 2,173.1
Gordon F. Brunner 643.1 1,629.8
<FN>
(1)All of these options, which were granted pursuant to The Procter &
Gamble 1992 Stock Plan, were non-qualified, were granted at market
value on the date of grant, vest on the first anniversary of the date
of grant, and have a term of ten years.
(2)We recommend caution in interpreting the financial significance of
these figures. They are calculated by multiplying the number of
options granted by the difference between a future hypothetical stock
price and the option exercise price and are shown pursuant to rules of
the Securities and Exchange Commission. They assume the value of
Company stock appreciates 5% or 10% each year, compounded annually, for
ten years (the life of each option). They are not intended to forecast
possible future appreciation, if any, of such stock price or to
establish a present value of options. Also, if appreciation does occur
at the 5% or 10% per year rate, the amounts shown would not be realized
by the recipients until the year 2004. Depending on inflation rates,
these amounts may be worth significantly less in 2004, in real terms,
than their value today. The Company has not used an alternative
formula for valuation as the Company is not aware of any formula which
will determine with reasonable accuracy a present value of options
based on future unknown or volatile factors.
</TABLE>
<TABLE>
AGGREGATED OPTION/STOCK APPRECIATION RIGHT (SAR)
EXERCISES IN LAST FISCAL YEAR
AND FISCAL YEAR-END OPTION/SAR VALUES(1)
(DOLLAR FIGURES SHOWN IN THOUSANDS)
<CAPTION>
Shares Number of Securities
Acquired Underlying Unexercised
on Value Options/SARs at FY End
__________________________
Name Exercise Realized(2) Exercisable Unexercisable
_____________ ________ ___________ ___________ _____________
<S> <C> <C> <C> <C>
Edwin L. Artzt 8,560 $309.4 464,080 64,000
John E. Pepper 37,000 931.9 290,000 45,000
Durk I. Jager 12,000 481.1 175,000 35,000
Harald Einsmann 0 0 180,200 24,000
Gordon F. Brunner 0 0 132,220 18,000
<CAPTION>
Value of Unexercised
In-the-Money
Options/SARs at FY End (3)
___________________________
Name Exercisable Unexercisable
_________________ ___________ _____________
<S> <C> <C>
Edwin L. Artzt $7,746.6 $0.0
John E. Pepper 4,472.3 0.0
Durk I. Jager 2,846.3 0.0
Harald Einsmann 3,422.6 0.0
Gordon F. Brunner 2,350.7 0.0
<FN>
(1)Optionees may satisfy the exercise price by submitting currently owned
shares and/or cash. Income tax withholding obligations may be
satisfied by electing to have the Company withhold shares otherwise
issuable under the option/stock appreciation right (SAR) with a fair
market value equal to such obligations.
(2)Options/SARs were granted for terms of up to ten years. The value
realized on options/SARs exercised during the last fiscal year
represents the total gain over the years the options/SARs were held by
the executive. If this total gain is divided by the average number of
years the options/SARs were held, a more
<PAGE>
relevant annualized gain is produced. The annualized gains (in
thousands of dollars) on these option/SAR exercises were as follows:
Mr. Artzt, $34.4; Mr. Pepper, $186.4; Mr. Jager, $60.1; Mr. Einsmann,
$0; and Mr. Brunner, $0.
(3)The fair market value of the Company's Common Stock on June 30, 1994
($54.0625 per share) minus the exercise price.
</TABLE>
RETIREMENT BENEFITS
Retirement benefits for U.S.-based executive officers are provided
primarily by The Procter & Gamble Profit Sharing Trust and Employee Stock
Ownership Plan. This is a defined contribution plan. Under the rules set
by the Securities and Exchange Commission, these Company contributions are
included in the Summary Compensation Table in the "All Other Compensation"
column (see footnote (5) to such Table). In addition, Mr. Einsmann and Mr.
Jager are enrolled in the Pension Plans of Procter & Gamble GmbH (Germany)
and Procter & Gamble Benelux N.V. (Netherlands Branch), respectively, where
they joined the Company. Mr. Jager is also enrolled in the Supplemental
Retirement Plan for U.S.-based managers who previously participated in
pension plans of international subsidiaries. These Plans are defined
benefit plans funded by book reserves or insurance contracts in order to
pay retirement benefits in cash. Given their age and service with the
Company, their estimated annual benefit, if payable in the form of a
straight annuity upon retirement at age 65, would be $854,437 for Mr.
Einsmann and $171,798 for Mr. Jager.
<PAGE>
COMPARISON OF FIVE-YEAR CUMULATIVE TOTAL RETURN
The following graph compares the five-year cumulative total return of
the Company's Common Stock as compared with the S&P 500 Stock Index and a
weighted composite of the S&P Household Products Index, the S&P Paper &
Forest Products Index, the S&P Cosmetics Index, the S&P Health Care
Diversified Index and the S&P Foods Index weighted based on the Company's
current fiscal year revenues.
{Performance Graph}
The graph assumes a $100 investment made on July 1, 1989 and the
reinvestment of all dividends, as follows:
<TABLE>
<CAPTION>
Dollar Value of $100 Investment at June 30
__________________________________________
1989 1990 1991 1992 1993 1994
____ ____ ____ ____ ____ ____
<S> <C> <C> <C> <C> <C> <C>
P&G Common $100.00 $163.14 $148.51 $180.87 $209.02 $222.58
Composite Group $100.00 $132.02 $145.60 $178.18 $192.17 $197.03
S&P 500 $100.00 $116.40 $125.01 $141.87 $161.14 $163.30
</TABLE>
<PAGE>
SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN BENEFICIAL OWNERS
The following tables give information concerning the beneficial
ownership of the Company's Common and Series A and B ESOP Convertible Class
A Preferred Stock by all Directors and nominees, all Directors and
executive officers as a group, and the owners of more than five percent of
the outstanding Series A and B ESOP Convertible Class A Preferred Stock, on
August 12, 1994:
<TABLE>
COMMON STOCK
<CAPTION>
Amount and Nature of Beneficial Ownership
Direct
(1) and Trusteeships
Profit Right and Percent
Sharing to Family of
Owner Plan (2) Acquire (3) Holdings(4) Class
___________________ _________ ___________ __________ ________
<S> <C> <C> <C> <C>
David M. Abshire 800.0 -- -- (5)
Edwin L. Artzt 330,164.4 464,080.0 -- (5)
Norman R. Augustine 3,000.0 -- -- (5)
Donald R. Beall 1,750.0 -- 1,000.0 (5)
Gordon F. Brunner 56,063.9 132,220.0 100.0 (5)
Richard B. Cheney 400.0 -- -- (5)
Harald Einsmann 8,594.0 180,200.0 -- (5)
Richard J. Ferris 28,800.0 -- -- (5)
Joseph T. Gorman 1,994.0 -- -- (5)
Robert A. Hanson 1,000.0 -- -- (5)
Durk I. Jager 36,622.4 175,000.0 -- (5)
Jerry R. Junkins 1,000.0 -- -- (5)
Joshua Lederberg 10,000.0 -- 3,686.0 (5)
Charles R. Lee 2,500.0 -- -- (5)
John E. Pepper 336,376.9 290,000.0 -- (5)
John G. Smale 99,702.0 -- 92,400.0 (5)
Robert D. Storey 400.0 -- -- (5)
Marina v.N. Whitman 2,400.0 -- -- (5)
37 Directors and
executive
officers,
as a group 1,648,487.1 2,738,790.0 103,590.5 .656%
<FN>
(1) Sole discretion as to voting and investment of shares.
(2) Shares allocated to personal accounts of executive officers under
appropriate Trust pursuant to The Procter & Gamble Profit Sharing Trust
and Employee Stock Ownership Plan. Plan participants have sole
discretion as to voting and, within limitations provided by the Plan,
investment of shares. Shares are voted by the appropriate Trustees in
accordance with instructions from participants. If instructions are
not received by the Trustees as to the voting of particular shares,
shares are to be voted in proportion to instructions actually received
from other participants in the same Trust.
(3) If acquired, would have sole discretion as to voting and investment
of shares.
(4) The individuals involved share voting and/or investment powers with
other persons.
(5) Less than .117% for any one Director.
</TABLE>
<PAGE>
<TABLE>
SERIES A ESOP CONVERTIBLE CLASS A PREFERRED STOCK
<CAPTION>
Amount and Nature of
Beneficial Ownership
__________________________
Profit Percent
Sharing of
Owner Plan (1) Trusteeships Series
____________________ ________ ____________ ______
<S> <C> <C> <C>
David M. Abshire - - -
Edwin L. Artzt 2,440.4 - (2)
Norman R. Augustine - - -
Donald R. Beall - - -
Gordon F. Brunner 2,440.4 - (2)
Richard B. Cheney - - -
Harald Einsmann - - -
Richard J. Ferris - - -
Joseph T. Gorman - - -
Robert A. Hanson - - -
Durk I. Jager 2,417.6 - (2)
Jerry R. Junkins - - -
Joshua Lederberg - - -
Charles R. Lee - - -
John E. Pepper 2,440.4 - (2)
John G. Smale - - -
Robert D. Storey - - -
Marina v.N. Whitman - - -
37 Directors and
executive
officers,
as a group 47,233.931 - .138%
Employee Stock Ownership
Trust of The Procter &
Gamble Profit Sharing
Trust and Employee Stock
Ownership Plan, PO Box
599, Cincinnati, Ohio
45201-0599 (O. B. Butler,
W. O. Coleman and
C. C. Carroll, Trustees)-- 24,242,460.9(3) 71.1%
<FN>
(1) Shares allocated to personal accounts of executive officers under the
Employee Stock Ownership Trust pursuant to The Procter & Gamble Profit
Sharing Trust and Employee Stock Ownership Plan. Plan participants
have sole discretion as to voting and, within limitations provided by
the Plan, investment of shares. Shares are voted by the Trustees of
such Trust in accordance with instructions from participants. If
instructions are not received by the Trustees as to the voting of
particular shares, shares are to be voted in proportion to
instructions actually received from other participants in the Trust.
(2) Less than .008% for any one Director; by the terms of the stock, only
persons who are or have been employees can have beneficial ownership
of these shares.
(3) Unallocated shares. The voting of these shares is governed by the
terms of the Plan, which provides that the Trustees shall vote
unallocated shares held by them in proportion to instructions received
from Trust participants as to voting of allocated shares. The
disposition of these shares in connection with a tender offer would be
governed by the terms of the Plan, which provides that the Trustees
shall dispose of unallocated shares held by them in proportion to
instructions received from Trust participants as to the disposition of
allocated shares.
</TABLE>
<PAGE>
<TABLE>
SERIES B ESOP CONVERTIBLE CLASS A PREFERRED STOCK
<CAPTION>
Amount and Nature of Beneficial Ownership
Profit Percent
Sharing of
Owner Plan (1) Trusteeships Series
<S> <C> <C> <C>
David M. Abshire - - -
Edwin L. Artzt 139.8 - (2)
Norman R. Augustine - - -
Donald R. Beall - - -
Gordon F. Brunner 39.2 - (2)
Richard B. Cheney - - -
Harald Einsmann - - -
Richard J. Ferris - - -
Joseph T. Gorman - - -
Robert A. Hanson - - -
Durk I. Jager - - -
Jerry R. Junkins - - -
Joshua Lederberg - - -
Charles R. Lee - - -
John E. Pepper 39.2 - (2)
John G. Smale 139.8 - (2)
Robert D. Storey - - -
Marina v.N. Whitman - - -
37 Directors and
executive officers,
as a group 576.2 - .003%
Employee Stock Ownership
Trust of The Procter
& Gamble Profit Sharing
Trust and Employee Stock
Ownership Plan, PO Box
599, Cincinnati, Ohio
45201-0599 (O. B. Butler,
W. O. Coleman and
C. C. Carroll, Trustees) - 17,473,011.3(3) 91.3%
<FN>
(1) Shares allocated to personal accounts of current and former executive
officers under the Employee Stock Ownership Trust pursuant to The
Procter & Gamble Profit Sharing Trust and Employee Stock Ownership
Plan. Plan participants have sole discretion as to voting and, within
limitations provided by the Plan, investment of shares. Shares are
voted by the Trustees of such Trust in accordance with instructions
from participants. If instructions are not received by the Trustees
as to the voting of particular shares, shares are to be voted in
proportion to instructions actually received from other participants
in the Trust.
(2) Less than .0008% for any one Director.
(3) Unallocated shares. The voting of these shares is governed by the
terms of the Plan, which provides that the Trustees shall vote
unallocated shares held by them in proportion to instructions received
from Trust participants as to voting of allocated shares. The
disposition of these shares in connection with a tender offer would be
governed by the terms of the Plan, which provides that the Trustees
shall dispose of unallocated shares held by them in proportion to
instructions received from Trust participants as to the disposition of
allocated shares.
</TABLE>
REPORTING OF SECURITIES TRANSACTIONS
Ownership of and transactions in Company stock by executive officers
and Directors of the Company are required to be reported to the Securities
and Exchange Commission pursuant to Section 16(a) of the Securities
Exchange Act of 1934. On March 22, 1994, Jorge P. Montoya, Group Vice
President, and a member of the Executive Committee, filed an amended Form 4
to correct the number of shares reported on February 28, 1994 as being held
directly by him as an executive officer. The original report had
inadvertently
<PAGE>
transposed two numbers. On August 11, 1994, Todd A. Garrett, Vice
President-Worldwide Strategic Planning, Beauty Care Products, and a member
of the Executive Committee, filed an amended Form 3 to report certain
securities that were inadvertently omitted from his original Form 3 and two
Form 5's to report certain transactions related to these securities over
the past two fiscal years. On January 20, 1994, Mr. Garrett also filed
amended Form 4's to correct an inadvertent omission of certain sales and
transfers of shares on the Form 4's filed October 7, 1993 and October 29,
1993.
TRANSACTIONS WITH EXECUTIVE OFFICERS, DIRECTORS AND OTHERS
During the past fiscal year, the Company and its subsidiaries had no
transaction in which any Director, or any member of the immediate family of
any Director, had a material direct interest reportable under applicable
rules of the Securities and Exchange Commission. In the normal course of
business the Company had transactions with other corporations where certain
Directors are or were executive officers; and the Company utilized the
services of the law firm of Thompson, Hine and Flory in which Robert D.
Storey, a Director, is a partner. None of the aforementioned matters was
material in amount as to the Company, the corporations or law firm.
During the past fiscal year, the Company and its subsidiaries had no
transactions in which any executive officer of the Company, or any member
of the immediate family of any such executive officer, had a material
direct or indirect interest reportable under applicable rules of the
Securities and Exchange Commission.
PROPOSAL TO RATIFY APPOINTMENT OF INDEPENDENT AUDITORS
The Board of Directors, acting upon the recommendation of the Audit
Committee of the Board, has appointed the firm of Deloitte & Touche as the
Company's independent auditors for fiscal year 1994-95. Although action by
the shareholders in this matter is not required, the Board believes that it
is appropriate to seek shareholder ratification of this appointment in
light of the critical role played by independent auditors in maintaining
the integrity of Company financial controls and reporting.
The following proposal will therefore be presented for action at the
annual meeting by direction of the Board of Directors:
RESOLVED, That action by the Board of Directors appointing Deloitte &
Touche as the Company's independent auditors to conduct the annual
audit of the financial statements of the Company and its subsidiaries
for the fiscal year ending June 30, 1995 is hereby ratified, confirmed
and approved.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THIS RESOLUTION FOR THE
FOLLOWING REASONS:
The Board of Directors first appointed Deloitte & Touche as the
Company's independent auditors in 1890 and has reappointed them to this
capacity each succeeding fiscal year. Deloitte & Touche has an outstanding
reputation in the auditing field and has served the Company well over the
intervening years. The Board of Directors and its Audit Committee believe
that such firm clearly has the necessary personnel, professional
qualifications and independence to continue to serve as the Company's
independent auditors.
In addition, Deloitte & Touche's longstanding service to the Company has
given it a unique understanding of the operations of Procter & Gamble,
thereby giving it a significant advantage over other firms in conducting a
knowledgeable and efficient audit.
One or more representatives of Deloitte & Touche will be in attendance
at the annual meeting on October 11, 1994. The representatives will have
the opportunity to make a statement, if desired, and will be available to
respond to appropriate questions from shareholders.
The affirmative vote of a majority of shares participating in the voting
on this proposal is required for adoption of this resolution. Proxies will
be voted FOR the resolution unless the Proxy Committee is instructed
otherwise on a proxy returned to such Committee. Abstentions indicated on
such a proxy card will not be counted as either "for" or "against" this
proposal.
<PAGE>
PROPOSAL TO RATIFY THE PROCTER & GAMBLE
1993 NON-EMPLOYEE DIRECTORS' STOCK PLAN
On November 9, 1993, the Board of Directors approved for submission to
the shareholders The Procter & Gamble 1993 Non-Employee Directors' Stock
Plan as set forth in Appendix A to this proxy statement. The resolution
which will be introduced at the shareholders meeting seeking approval of
such Plan is as follows:
RESOLVED, That The Procter & Gamble 1993 Non-Employee Directors'
Stock Plan adopted by the Board of Directors, as set forth in Appendix
A to the proxy statement for this meeting, is hereby ratified and
authorized.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THIS RESOLUTION FOR THE
FOLLOWING REASONS:
The Procter & Gamble 1993 Non-Employee Directors' Stock Plan (the
"Plan") is designed to strengthen the alignment of interest between non-
employee Directors (the "Participants") and the shareholders through the
increased ownership of shares of the Company's Common Stock. This will be
accomplished by allowing Participants to elect voluntarily to convert a
portion or all of their fees for services as a Director into Common Stock.
The Plan will be administered by the Compensation Committee (the
"Committee") of the Board of Directors. The total number of shares of
Common Stock that may be awarded each year will not exceed 25,000 shares.
The shares awarded will be valued at the average of the high and low
quotations for Common Stock of the Company on The New York Stock Exchange
on the day of the transfer to a Participant. All shares awarded will be
full shares, rounded up to the nearest whole share. The shares awarded may
be subject to such conditions and restrictions, if any, as the Committee
may determine.
The Plan became effective as of January 1, 1994 subject to ratification
before December 31, 1994 by the affirmative vote of the holders of a
majority of the Common Stock of the Company present, or represented, and
entitled to vote at a meeting duly held. Proxies will be voted FOR the
resolution unless the Proxy Committee is instructed otherwise on a proxy
returned to such Committee. Abstentions indicated on such a proxy card
will be counted as a vote AGAINST this proposal. "Broker non-votes"
specified on proxies returned by brokers holding shares for beneficial
owners who have not provided instructions as to voting on this issue will
be treated as not present for voting on this issue.
Any shares awarded prior to approval of the Plan by the shareholders
have been restricted until such approval is obtained and are subject to
immediate forfeiture in the event such approval is not obtained in which
case the Participants will receive the fees they would have received for
their services as Directors since January 1, 1994 plus interest computed as
of the end of each month at the prime rate then in effect at Morgan
Guaranty Trust Company of New York. The Plan will terminate on December
31, 2003 unless a different termination date is fixed by the shareholders
or by action of the Board of Directors, but no such termination shall
affect the prior rights under the Plan of the Company or of anyone to whom
shares have been transferred prior to such termination.
SHAREHOLDER PROPOSALS
The following proposals, each of which is opposed by the Board of
Directors, would require the affirmative vote of a majority of the votes
cast on each such proposal for adoption.
<PAGE>
SHAREHOLDER PROPOSAL NO. 1
Evelyn Y. Davis, Watergate Office Building, 2600 Virginia Avenue, N.W.,
Suite 215, Washington, DC 20037, owning 200 shares of Common Stock of the
Company, has given notice that she intends to present for action at the
annual meeting the following resolution:
RESOLVED: That the shareholders of P&G recommend that the Board of
Directors take the necessary steps to reinstate the election of
directors ANNUALLY, instead of the stagger system which was recently
adopted.
Mrs. Davis has submitted the following statement in support of her
resolution:
REASONS: Until recently, directors of P&G were elected annually by
all shareholders.
The great majority of New York Stock Exchange listed corporations
elect all their directors each year.
This insures that ALL directors will be more accountable to ALL
shareholders each year and to a certain extent prevents the self-
perpetuation of the Board.
Last year the owners of 152,513,760 shares representing
approximately 26.3% of shares voting, voted FOR this proposal.
If you AGREE, please mark your proxy FOR this resolution.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE AGAINST THIS RESOLUTION FOR THE
FOLLOWING REASONS:
The shareholders of Procter & Gamble decided, by action at the annual
meeting of shareholders in 1985, that its Board of Directors shall be
divided into three classes with Directors elected to staggered three-year
terms. This was to insure continuity of experienced Board members.
This exercise by Procter & Gamble shareholders of their rightful role in
corporate governance has been challenged with this same resolution at every
annual meeting since 1986. On each of these occasions, the shareholders
confirmed that they wanted to retain the continuity of experienced
Directors by having a classified Board of Directors with staggered terms.
In each such year they defeated the proposal to return to annual election
of the entire Board, with over 73% voting against it at the most recent
shareholders meeting.
This year's resolution and the arguments in support of it are identical
to those in prior years. The Board of Directors agrees with the results of
previous shareholder voting on this issue and again recommends a vote
AGAINST the proposal.
The affirmative vote of a majority of shares participating in the voting
on this proposal is required for adoption of this resolution. Proxies will
be voted AGAINST the resolution unless the Proxy Committee is instructed
otherwise on a proxy returned to such Committee. Abstentions indicated on
such a proxy card will not be counted as either "for" or "against" this
proposal. "Broker non-votes" specified on proxies returned by brokers
holding shares for beneficial owners who have not provided instructions as
to voting on this issue will be treated as not present for voting on this
issue.
SHAREHOLDER PROPOSAL NO. 2
Alan Hevesi, Comptroller of the City of New York and custodian and
trustee of the New York City Employees' Retirement System, 1 Centre Street,
New York, NY 10007-2341, owning 2,235,174 shares of Common Stock of the
Company, has given notice that they intend to present for action at the
annual meeting the following resolution:
<PAGE>
WHEREAS WE BELIEVE:
The responsible implementation of sound environmental policy
increases long-term shareholder value by increasing efficiency,
decreasing clean-up costs, reducing litigation, and enhancing public
image and product attractiveness;
Adherence to public standards for environmental performance gives a
company greater public credibility than is achieved by following
standards created by industry alone. In order to maximize public
credibility and usefulness, such standards also need to reflect what
investors and other stakeholders want to know about the environmental
records of their companies;
Standardized environmental reports will provide shareholders with
useful information which allows comparison of performance against
uniform standards and comparisons of progress over time. Companies can
also attract new capital from investors seeking investments that are
environmentally responsible, responsive, progressive, and which
minimize the risk of environmental liability.
AND WHEREAS:
The Coalition for Environmentally Responsible Economies (CERES),
which comprises large institutional investors with $150 billion in
stockholdings (including shareholders of this Company), public interest
representatives, and environmental experts, consulted with dozens of
corporations and produced comprehensive public standards for both
environmental performance and reporting. Over 50 companies, including
the Sun Company, a Fortune-500 company, have endorsed the CERES
Principles to demonstrate their commitment to public environmental
accountability.
In endorsing the CERES Principles, a company commits to work toward:
1. Protection of the biosphere
2. Sustainable use of natural resources and services
3. Waste reduction and disposal
4. Energy conservation
5. Risk reduction
6. Safe products
7. Environmental restoration
8. Informing the public
9. Management commitment
10.Audits and reports
The full text of the CERES Principles and the accompanying CERES
Report Form are available from CERES, 711 Atlantic Avenue, Boston MA
02110. Telephone: (617) 451-0927.
Concerned investors are asking the Company to be publicly
accountable for its environmental impact, including collaboration with
this corporate, environmental, investor, and community coalition to
develop:
(a)standards for environmental performance and disclosure;
(b)appropriate goals relative to these standards;
(c) evaluation methods and tools for
measurement of progress toward these goals; and
(d)a format for public reporting of this progress.
<PAGE>
We believe this request is consistent with regulation adopted by the
European Community for companies' voluntary participation in verified
and publicly-reported eco-management and auditing.
RESOLVED: Shareholders request the Company to endorse the CERES
Principles as a commitment to be publicly accountable for its
environmental impact.
The New York City Employees' Retirement System has submitted the
following statement in support of their resolution:
We invite the Company to endorse the CERES Principles by:
(1)stating its endorsement in a letter signed by a senior officer;
(2)committing to implement the Principles; and
(3)annually completing the CERES Report.
Endorsing these Principles complements rather than supplants
internal corporate environmental policies and procedures.
We believe that without this public scrutiny, corporate
environmental policies and reports lack the critical component of
adherence to standards set not only by management but also by other
stakeholders. Shareholders are asked to support this resolution, to
encourage our Company to demonstrate environmental leadership and
accountability for its environmental impact.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE AGAINST THIS RESOLUTION FOR THE
FOLLOWING REASONS:
We believe adopting the CERES Principles would not provide any greater
environmental protection and could divert resources to additional audit
requirements and reports called for by the Principles.
P&G supports the spirit of the CERES Principles and already has an
Environmental Quality Policy that includes the following elements:
- - - -- Providing safe products, packaging and operations for employees,
consumers and the environment;
- - - -- Reducing or preventing the environmental impact of the Company's
products and packaging in their design, manufacture, distribution, use
and disposal whenever possible;
- - - -- Ensuring that every employee understands and is responsible and
accountable for incorporating environmental considerations in daily
business activities.
P&G continually strives to improve the environmental quality of its
products through a steadfast commitment to innovation. For example, P&G
has pioneered packaging reductions by introducing compact laundry
detergents and product refills, substantially cutting the volume of
material entering the waste stream. The Company also strives to improve
the environmental performance of its manufacturing operations and has been
a leader in applying Total Quality Management practices to this area.
P&G is recognized around the world by many peer companies, policy-
makers, environmental groups and consumers as an environmental leader. One
reason, we believe, is that the Company is committed to continual
environmental improvement.
This commitment, along with publicly stated goals, an on-going program
of audits and reports, and the requirement to comply with extensive
regulation from localities, states, the U.S. federal government and other
nations, already provides a strong basis of accountability to the public
and shareholders alike.
The Board does not believe that adoption of another set of principles,
on top of the Company's strong environmental quality policy and programs,
would help P&G better fulfill its commitment to environmental quality.
<PAGE>
Therefore, the Board of Directors recommends a vote AGAINST this
proposal.
The affirmative vote of a majority of shares participating in the voting
on this proposal is required for adoption of this resolution. Proxies will
be voted AGAINST the resolution unless the Proxy Committee is instructed
otherwise on a proxy returned to such Committee. Abstentions indicated on
such a proxy card will not be counted as either "for" or "against" this
proposal. "Broker non-votes" specified on proxies returned by brokers
holding shares for beneficial owners who have not provided instructions as
to voting on this issue will be treated as not present for voting on this
issue.
SHAREHOLDER PROPOSAL NO. 3
Jayn Meinhardt, M.Ed., 1501 East McMillan, Cincinnati, Ohio 45206,
owning 24 shares of Common Stock of the Company, and Sandy Caron, 3531 Glen
Edge Lane, Cincinnati, Ohio 45213, owning 4,000 shares of Common Stock of
the Company, have given notice that they intend to present for action at
the annual meeting the following resolution:
WHEREAS, Procter & Gamble manufactures over-the-counter cosmetics
and non-medical household products; and
WHEREAS, Procter & Gamble, its contractors or ingredient suppliers
test the ingredients in these products, or the actual products
themselves on animals; and
WHEREAS, these animal tests are considered by Procter & Gamble to be
a measuring stick of product safety for accidents or misuse of our
products; and
WHEREAS, through the "Up/down LD50", the "Low Volume Eye Tests"
(LVET) and other tests, corneal and other tissue damage and actual
deaths may occur to the animals; and
WHEREAS, the public has no way of ascertaining when they purchase a
product if said product or its ingredients have caused harm to or
killed animals,
BE IT RESOLVED THAT it is recommended to the Board of Directors that
Procter & Gamble will release to the public, through product labeling,
the results of our "Up/down LD50", "Low Volume Eye Test", or other
tests on animals, on these over-the-counter cosmetics and non-medical
household products.
Ms. Meinhardt and Ms. Caron have submitted the following statement in
support of their resolution:
Because the stated intent of Procter & Gamble's animal tests is to
ascertain if products will cause harm to people, it would be in our
company's best interests to allow the public to know if a finished
product, or any of its ingredients, has blinded, caused tissue damage
to, or killed animals.
As consumer interest grows in product labeling, this information
will alert parents, and others, to the specific injuries (or deaths)
that occurred to test animals, so that they can make informed choices.
It is our understanding that the scientists who conduct safety tests at
our company's product testing laboratories are only allowed to identify
products or ingredients by codes, and even these scientists have no way
of independently ascertaining if a substance that killed animals is
later marketed.
Many parents (and others) now believe that if a product or its
ingredients have caused harm to animals that product will not be
marketed. If products, or their ingredients, have caused tissue damage
to animals, and these results are supposed to be applicable to similar
reactions in humans, we believe the public has the right to this
knowledge.
<PAGE>
THE BOARD OF DIRECTORS RECOMMENDS A VOTE AGAINST THIS RESOLUTION FOR THE
FOLLOWING REASONS:
First, the type of product labeling suggested in this proposal is
unnecessary.
Several federal government agencies, including the U.S. Food and Drug
Administration, already mandate strict labeling guidelines for consumer
products. P&G follows these guidelines. As a result, we already provide
consumers with label information they need to make "informed decisions,"
the expressed intent of this proposal.
P&G products are proven safe for their intended uses and foreseeable
misuse. If there are risks associated with our products or their
ingredients, these risks are already pointed out on the labels, as required
by law. For example, products which shouldn't be ingested say: "For
external use only."
Second, the labeling proposed could actually mislead consumers.
The purpose of safety or warning labels is to give people good, simple
information they can use. In fact, the regulatory agencies responsible for
consumer product labeling discourage labeling which isn't clearly
actionable or where individual pieces of research data aren't directly
relevant to the total safety picture of the product.
When animal tests are used to establish the safety of a new ingredient
or product, they're only one part of a total safety assessment. Isolating
a single piece of such an assessment -- and labeling the product as "toxic
to animals" -- could needlessly alarm people about the true safety of that
product.
Consider, for example, cleaning and personal care products containing
salt, an ingredient commonly used as a thickener. Used this way, salt is
safe. However, at very high levels, it can be toxic to animals and people.
Under this proposal, we would be required to label products containing salt
as toxic to animals. The same holds true for many common ingredients.
This kind of labeling would only confuse people.
Finally, this proposal essentially duplicates other resolutions on
animal testing in recent years which our shareholders have overwhelmingly
defeated.
These proposals have been defeated because the vast majority of our
shareholders support our policy. They understand we are fulfilling our
responsibility to ensure our products are safe. They understand we use
animals only if other methods cannot assure us and international regulatory
authorities of that safety. They understand that we always use the
smallest number of animals possible and treat those animals humanely and
with respect. And they appreciate the strong progress we continue to make
in reducing our use of animals in safety testing, including by developing
and using alternative test methods.
P&G gives consumers the information they need about our products on the
label, and we comply with all labeling laws. The labeling required by this
proposal, though, would be excessive and misleading to consumers about the
safety of our brands.
Accordingly, the Board of Directors recommends a vote AGAINST this
proposal.
The affirmative vote of a majority of shares participating in the voting
on this proposal is required for adoption of this resolution. Proxies will
be voted AGAINST the resolution unless the Proxy Committee is instructed
otherwise on a proxy returned to such Committee. Abstentions indicated on
such a proxy card will not be counted as either "for" or "against" this
proposal. "Broker non-votes" specified on proxies returned by brokers
holding shares for beneficial owners who have not provided instructions as
to voting on this issue will be treated as not present for voting on this
issue.
<PAGE>
1995 ANNUAL MEETING DATE
It is anticipated that the 1995 annual meeting of shareholders will be
held on Tuesday, October 10, 1995. Pursuant to regulations issued by the
Securities and Exchange Commission, to be considered for inclusion in the
Company's proxy statement for presentation at that meeting, all shareholder
proposals must be received by the Company on or before the close of
business on Friday, May 5, 1995.
OTHER MATTERS
No action will be taken with regard to the minutes of the annual meeting
of shareholders held October 12, 1993 unless they have been incorrectly
recorded.
The Board of Directors knows of no other matters which will come before
the meeting. However, if any matters other than those set forth in the
notice should be properly presented for action, the persons named in the
proxy intend to take such action as will be in harmony with the policies of
the Company and, in that connection, will use their discretion.
<PAGE>
APPENDIX A
THE PROCTER & GAMBLE 1993 NON-EMPLOYEE DIRECTORS'
STOCK PLAN
ARTICLE A -- PURPOSE.
The purpose of The Procter & Gamble 1993 Non-Employee Directors' Stock
Plan (hereinafter referred to as the "Plan") is to strengthen the alignment
of interests between non-employee directors (hereinafter referred to as
"Participants") and the shareholders of The Procter & Gamble Company
(hereinafter referred to as the "Company") through the increased ownership
of shares of the Company's Common Stock. This will be accomplished by
allowing Participants to elect voluntarily to convert a portion or all of
their fees for services as a director into Common Stock.
ARTICLE B -- ADMINISTRATION.
1. The Plan shall be administered by the Compensation Committee
(hereinafter referred to as the "Committee") of the Board of Directors of
the Company (hereinafter referred to as the "Board"), or such other
committee as may be designated by the Board. The Committee shall consist
of not less than three (3) members of the Board who are neither officers
nor employees, or members of the Board who are "disinterested persons" as
defined in Rule 16b-3 under the Securities Exchange Act of 1934, as amended
(hereinafter referred to as the "1934 Act"), or any successor rule or
definition adopted by the Securities and Exchange Commission, to be
appointed by the Board from time to time and to serve at the discretion of
the Board.
2. It shall be the duty of the Committee to administer this Plan in
accordance with its provisions and to make such recommendations of
amendments or otherwise as it deem necessary or appropriate. A decision by
a majority of the Committee shall govern all actions of the Committee.
3. Subject to the express provisions of this Plan, the Committee
shall have authority to allow Participants the right to elect to receive
fees for services as a director in either cash or an equivalent amount of
whole shares of Common Stock of the Company, or partly in cash and partly
in whole shares of the Common Stock of the Company, subject to such
conditions or restrictions, if any, as the Committee may determine. The
Committee also has the authority to make all other determinations it deems
necessary or advisable for administering this Plan.
4. The Committee may establish from time to time such regulations,
provisions, and procedures within the terms of this Plan as, in its
opinion, may be advisable in the administration of this Plan.
5. The Committee may designate the Secretary of the Company or other
employees of the Company to assist the Committee in the administration of
this Plan and may grant authority to such persons to execute documents on
behalf of the Committee.
ARTICLE C -- PARTICIPATION.
Participation in the Plan shall be limited to all non-employee
Directors of the Company.
ARTICLE D -- LIMITATION ON NUMBER OF SHARES FOR THE PLAN.
1. The total number of shares of Common Stock of the Company that
may be awarded each year shall not exceed 25,000 shares.
2. Shares transferred or reserved for purposes of the Plan will be
subject to appropriate adjustment in the event of future stock splits,
stock dividends or other changes in capitalization; following any such
change, the term "Common Stock" or "shares of Common Stock" of the Company,
as used in the Plan, shall be deemed to refer to such class of shares or
other securities as may be applicable.
<PAGE>
ARTICLE E -- SHARES SUBJECT TO USE UNDER THE PLAN.
Shares of Common Stock to be awarded under the terms of this Plan
shall be treasury shares.
ARTICLE F -- TRANSFER OF SHARES.
1. The Committee may transfer Common Stock of the Company under the
Plan subject to such conditions or restrictions, if any, as the Committee
may determine. The conditions and restrictions may vary from time to time
and may be set forth in agreements between the Company and the Participant
or in the awards of stock to them, all as the Committee determines.
2. The shares awarded shall be valued at the average of the high and
low quotations for Common Stock of the Company on the New York Stock
Exchange on the day of the transfer to a Participant. All shares awarded
shall be full shares, rounded up to the nearest whole share.
ARTICLE G -- ADDITIONAL PROVISIONS.
1. The Board may, at any time, repeal this Plan or may amend it from
time to time except that no such amendment may amend this paragraph,
increase the annual aggregate number of shares subject to this Plan, or
alter the persons eligible to participate in this Plan. The Participants
and the Company shall be bound by any such amendments as of their effective
dates, but if any outstanding awards are affected, notice thereof shall be
given to the holders of such awards and such amendments shall not be
applicable to such holder without his or her written consent. If this Plan
is repealed in its entirety, all theretofore awarded shares subject to
conditions or restrictions transferred pursuant to this Plan shall continue
to be subject to such conditions or restrictions.
2. Every recipient of shares pursuant to this Plan shall be bound by
the terms and provisions of this Plan and of the transfer of shares
agreement referable thereto, and the acceptance of any transfer of shares
pursuant to this Plan shall constitute a binding agreement between the
recipient and the Company.
ARTICLE H -- DURATION OF PLAN.
This Plan shall become effective as of January 1, 1994 subject to
ratification before December 31, 1994 by the affirmative vote of the
holders of a majority of the Common Stock of the Company present, or
represented, and entitled to vote at a meeting duly held. Any shares
awarded prior to approval of the Plan by the shareholders must be
restricted until such approval is obtained and shall be subject to
immediate forfeiture in the event such approval is not obtained in which
case the Participants would receive the fees they would have received for
their services as Directors since January 1, 1994 plus interest computed
as of the end of each month at the prime rate then in effect at Morgan
Guaranty Trust Company of New York. This Plan will terminate on December
31, 2003 unless a different termination date is fixed by the shareholders
or by action of the Board but no such termination shall affect the prior
rights under this Plan of the Company or of anyone to whom shares have been
transferred prior to such termination.
<PAGE>
PRINTED WITH
SOY INK
PRINTED ON RECYCLED PAPER
#038-7079
<PAGE>
THE PROCTER & GAMBLE COMPANY
P&G Shareholder's Proxy Card
Annual Meeting of Shareholders--Tuesday, October 11, 1994
The undersigned hereby appoints Edwin L. Artzt, John E. Pepper
and Durk I. Jager, and each of them, as proxies to attend the annual
meeting of shareholders of the Company to be held on Tuesday, October
11, 1994 at 12 o'clock noon in Cincinnati, Ohio and any adjournment
thereof and vote shares of Common Stock held by the undersigned
directly or via the Company's Dividend Reinvestment Plan or Stock
Investment Program as indicated on the reverse side of this card: for
the election of Directors; upon the Board of Directors and shareholder
proposals listed; and, finally, upon such other matters as may
properly come before the meeting.
THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS OF THE PROCTER
& GAMBLE COMPANY PURSUANT TO A SEPARATE NOTICE OF ANNUAL MEETING AND
PROXY STATEMENT, RECEIPT OF WHICH IS HEREBY ACKNOWLEDGED. THIS CARD
SHOULD BE MAILED IN THE ENCLOSED ENVELOPE IN TIME TO REACH THE
COMPANY'S PROXY TABULATOR, CHEMICAL BANK, CHURCH STREET STATION, PO
BOX 24966, NEW YORK, NY 10242-4966, BY 9:00 A.M. ON TUESDAY, OCTOBER
11, 1994. INDIVIDUAL PROXY VOTING WILL BE KEPT CONFIDENTIAL BY
CHEMICAL BANK AND NOT PROVIDED TO THE COMPANY.
(CONTINUED AND TO BE SIGNED ON OTHER SIDE)
______________________________________________________________________
FOLD AND DETACH HERE
PLEASE REMOVE THIS PORTION BEFORE RETURNING PROXY
<PAGE>
(CONTINUED FROM OTHER SIDE)
P&G THE PROCTER & GAMBLE COMPANY Please mark your
votes as this in X
______________ blue or black ink
Account Number
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE FOLLOWING ACTIONS OR
PROPOSALS (AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT). IF YOU
SIGN AND RETURN THIS CARD WITHOUT MARKING, THIS PROXY CARD WILL BE
TREATED AS BEING FOR EACH ITEM.
ELECTION OF DIRECTORS (terms expiring in 1997)
Nominees: David M. Abshire, Edwin L. Artzt, Norman R. Augustine,
Richard J. Ferris, John G. Smale, Marina v.N. Whitman
FOR* WITHHELD *EXCEPT:______________
___ ___ _____________________
RATIFY APPOINTMENT OF INDEPENDENT AUDITORS
FOR AGAINST ABSTAIN
___ ___ ___
RATIFY ADOPTION OF 1993 NON-EMPLOYEE
DIRECTORS' STOCK PLAN
FOR AGAINST ABSTAIN
___ ___ ___
THE BOARD OF DIRECTORS RECOMMENDS A VOTE AGAINST THE FOLLOWING
SHAREHOLDER PROPOSALS (AS DESCRIBED IN THE ACCOMPANYING PROXY
STATEMENT), IF PRESENTED AT THE ANNUAL MEETING. IF YOU SIGN AND
RETURN THIS CARD WITHOUT MARKING, THIS PROXY CARD WILL BE TREATED AS
BEING AGAINST EACH PROPOSAL.
1. BOARD OF DIRECTORS TERMS
FOR AGAINST ABSTAIN
___ ___ ___
2. ENDORSE CERES PRINCIPLES
FOR AGAINST ABSTAIN
___ ___ ___
3. ANIMAL TESTING LABELING
FOR AGAINST ABSTAIN
___ ___ ___
PLEASE SIGN HERE exactly as
your name(s) appears to the left.
Give title if you sign as executor,
administrator, trustee, guardian
or corporate officer.
Signature
Signature
Date
Printed on recycled paper
_______________________________________________________________________
FOLD AND DETACH HERE
PLEASE REMOVE THIS PORTION BEFORE RETURNING PROXY
<PAGE>
THE PROCTER & GAMBLE COMPANY
P&G
Shareholder's Proxy and Confidential
Voting Instruction Card
Annual Meeting of Shareholders--Tuesday, October 11, 1994
The undersigned hereby appoints Edwin L. Artzt, John E. Pepper
and Durk I. Jager, and each of them (with respect to any shares of
Common Stock held by the undersigned directly or via the Company's
Stock Investment Program) as proxies to attend the annual meeting of
shareholders of the Company to be held on Tuesday, October 11, 1994 at
12 o'clock noon in Cincinnati, Ohio and any adjournment thereof and
vote, and directs the Trustees of the Long-term Incentive Trust or the
Retirement Distribution Trust and the Employee Stock Ownership Trust
of The Procter & Gamble Profit Sharing Trust and Employee Stock
Ownership Plan (as applicable, with respect to shares of Common Stock
and Series A and B ESOP Convertible Class A Preferred Stock held for
the benefit of the undersigned) and/or the Trustees of The Procter &
Gamble/Noxell Transitional Plan to vote in person or by proxy at such
annual meeting, all shares held by or for the benefit of the
undersigned as indicated on the reverse side of this card: for the
election of Directors; upon the Board of Directors and shareholder
proposals listed; and, finally, upon such other matters as may
properly come before the meeting.
THIS PROXY/VOTING INSTRUCTION CARD IS SOLICITED JOINTLY BY THE
BOARD OF DIRECTORS OF THE PROCTER & GAMBLE COMPANY AND THE TRUSTEES OF
THE PLAN TRUSTS LISTED ABOVE PURSUANT TO A SEPARATE NOTICE OF ANNUAL
MEETING AND PROXY STATEMENT, RECEIPT OF WHICH IS HEREBY ACKNOWLEDGED.
THIS CARD SHOULD BE MAILED IN THE ENCLOSED ENVELOPE IN TIME TO REACH
THE COMPANY'S PROXY TABULATOR, CHEMICAL BANK, CHURCH STREET STATION,
PO BOX 24966, NEW YORK, NY 10242-4966, BY 9:00 A.M. ON TUESDAY,
OCTOBER 11 FOR COMMON SHARES TO BE VOTED AND 5:00 P.M. ON MONDAY,
OCTOBER 10, 1994 FOR THE TRUSTEES TO VOTE THE PLAN SHARES. CHEMICAL
BANK WILL REPORT SEPARATELY TO THE PROXY COMMITTEE AND TO THE TRUSTEES
AS TO PROXIES RECEIVED AND VOTING INSTRUCTIONS PROVIDED, RESPECTIVELY.
INDIVIDUAL PROXY VOTING AND VOTING INSTRUCTIONS WILL BE KEPT
CONFIDENTIAL BY CHEMICAL BANK AND NOT PROVIDED TO THE COMPANY.
The Trustees of each Trust will vote shares of the Company's
Common Stock held by them for which instructions are not received in
direct proportion to the voting of shares for which instructions have
been received, provided that such voting is not contrary to the
Employee Retirement Income Security Act of 1974, as amended ("ERISA").
The Trustees will vote unallocated shares, and allocated shares for
which instructions are not received, of the Company's Series A and B
ESOP Convertible Class A Preferred Stock in direct proportion to
voting by allocated shares of such Series, in aggregate, for which
instructions have been received, provided that such voting is not
contrary to ERISA.
(CONTINUED AND TO BE SIGNED ON OTHER SIDE)
________________________________________________________________________
FOLD AND DETACH HERE
PLEASE REMOVE THIS PORTION BEFORE RETURNING PROXY
<PAGE>
(Continued from other side)
P&G THE PROCTER & GAMBLE COMPANY Please mark your
votes as this in X
blue or black ink
_____________
Account Number
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE FOLLOWING ACTIONS OR
PROPOSALS (AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT). IF YOU
SIGN AND RETURN THIS CARD WITHOUT MARKING, THIS PROXY CARD WILL BE
TREATED AS BEING FOR EACH ITEM.
ELECTION OF DIRECTORS (terms expiring in 1997)
Nominees: David M. Abshire, Edwin L. Artzt, Norman R. Augustine,
Richard J. Ferris, John G. Smale, Marina v.N. Whitman
FOR* WITHHELD *EXCEPT:______________
___ ___ _____________________
RATIFY APPOINTMENT OF INDEPENDENT AUDITORS
FOR AGAINST ABSTAIN
___ ___ ___
RATIFY ADOPTION OF 1993 NON-EMPLOYEE
DIRECTORS' STOCK PLAN
FOR AGAINST ABSTAIN
___ ___ ___
THE BOARD OF DIRECTORS RECOMMENDS A VOTE AGAINST THE FOLLOWING
SHAREHOLDER PROPOSALS (AS DESCRIBED IN THE ACCOMPANYING PROXY
STATEMENT), IF PRESENTED AT THE ANNUAL MEETING. IF YOU SIGN AND
RETURN THIS CARD WITHOUT MARKING, THIS PROXY CARD WILL BE TREATED AS
BEING AGAINST EACH PROPOSAL.
1. BOARD OF DIRECTORS TERMS
FOR AGAINST ABSTAIN
___ ___ ___
2. ENDORSE CERES PRINCIPLES
FOR AGAINST ABSTAIN
___ ___ ___
3. ANIMAL TESTING LABELING
FOR AGAINST ABSTAIN
___ ___ ___
PLEASE SIGN HERE exactly as
your name appears to the left
Signature
Date
Printed on recycled paper
________________________________________________________________________
FOLD AND DETACH HERE
PLEASE REMOVE THIS PORTION BEFORE RETURNING PROXY
<PAGE>
P&G
September 27, 1994
Dear Shareholder:
On September 2, 1994 we sent you a notice and proxy
statement plus proxy card for the annual meeting of The
Procter & Gamble Company to be held on Tuesday, October
11, 1994.
As of this date your proxy card has not been received
by Chemical Bank, the Company's proxy tabulators for
this year's meeting. If you have in fact already
mailed your card, we thank you. If not, we hope you
will do this now.
In case you have lost the original card and need a new
one to respond at this time, we enclose a duplicate
together with a return envelope addressed to Chemical
Bank. Thank you for your attention to this matter.
THE PROCTER & GAMBLE COMPANY
